| Product Code: ETC9938954 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Bacteriophages Therapy Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Bacteriophages Therapy Market - Industry Life Cycle |
3.4 United Kingdom (UK) Bacteriophages Therapy Market - Porter's Five Forces |
3.5 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections in the UK |
4.2.2 Growing awareness about the effectiveness of bacteriophages therapy |
4.2.3 Government initiatives promoting the use of alternative therapies in healthcare |
4.3 Market Restraints |
4.3.1 Limited research and development in the field of bacteriophages therapy |
4.3.2 Regulatory challenges and approval processes for phage therapy products in the UK |
5 United Kingdom (UK) Bacteriophages Therapy Market Trends |
6 United Kingdom (UK) Bacteriophages Therapy Market, By Types |
6.1 United Kingdom (UK) Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 United Kingdom (UK) Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 United Kingdom (UK) Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 United Kingdom (UK) Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 United Kingdom (UK) Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Bacteriophages Therapy Market Export to Major Countries |
7.2 United Kingdom (UK) Bacteriophages Therapy Market Imports from Major Countries |
8 United Kingdom (UK) Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials conducted for bacteriophages therapy in the UK |
8.2 Adoption rate of bacteriophages therapy by healthcare providers in the UK |
8.3 Investment in research and development of bacteriophages therapy technologies |
9 United Kingdom (UK) Bacteriophages Therapy Market - Opportunity Assessment |
9.1 United Kingdom (UK) Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 United Kingdom (UK) Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 United Kingdom (UK) Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United Kingdom (UK) Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Bacteriophages Therapy Market - Competitive Landscape |
10.1 United Kingdom (UK) Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here